Buy Neuralstem Stock | CUR Stock Price & Latest News | Public
CUR

Neuralstem

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About CUR

    Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small mol...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Stats

    Market Cap$10,37M
    Volume5,22k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.09
    1 Year Low$0.50
    Open$0.61
    High$0.61
    Low$0.59

    Buy any stock with any amount of money.

    Download the App
    Download the app